Similar Search Results

Characterizing information barriers to entry in the anti-ulcer drug market

Shum, Matthew (contributor) - 1998 - [Elektronische Ressource]

Persistent link: https://www.econbiz.de/10001591809

Incentives for clinical trials

Grönqvist, Erik; Lundin, Douglas - In: Economics of innovation and new technology 18 (2009) 5/6, pp. 513-531

Persistent link: https://www.econbiz.de/10003897678

Incentive alignment and information elicitation from manufacturers for public goods procurement

Chick, Stephen E.; Hasija, Sameer; Nasiry, Javad - 2012

Persistent link: https://www.econbiz.de/10009572856

Can good products drive out bad? : evidence from local markets for (fake?) antimalarial medicine in Uganda

Björkman-Nyqvist, Martina; Svensson, Jakob; … - 2012

Persistent link: https://www.econbiz.de/10009621935

Can good products drive out bad? : evidence from local markets for (fake?) antimalarial medicine in Uganda

Björkman-Nyqvist, Martina; Svensson, Jakob; … - 2012

Persistent link: https://www.econbiz.de/10009630358

Three essays in applied health economics

Schmid, Christian - 2014 - Als Ms. gedr.

Persistent link: https://www.econbiz.de/10010401792

Consequences of disclosing clinical trial results : evidence from the food and drug administration amendments act

Bourveau, Thomas; Capkun, Vedran; Wang, Yin - 2020

We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics,...

Persistent link: https://www.econbiz.de/10012295656

The signaling effects of the US food and drug administration fast-track designation

Miller, Kathleen L.; Nardinelli, Clark; Pink, George H.; … - In: Managerial and decision economics : MDE ; the … 38 (2017) 4, pp. 581-594

Persistent link: https://www.econbiz.de/10011738902

Biopharmaceutical patents : multifaceted signals, reducing and enhancing knowledge asymmetries in drug discovery

Levitas, Edward; MacFadyen, M. Ann - In: Technology analysis & strategic management 35 (2023) 4, pp. 438-450

Persistent link: https://www.econbiz.de/10014301320

Can good products drive out bad? : a randomized intervention in the antimalarial medicine market in Uganda

Björkman-Nyqvist, Martina; Svensson, Jakob; … - In: Journal of the European Economic Association : JEEA 20 (2022) 3, pp. 957-1000

Persistent link: https://www.econbiz.de/10013349199